These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
292 related articles for article (PubMed ID: 28845038)
1. Treatment Recommendations for Adult Patients with Diffuse Gliomas of Grades II and III According to the New WHO Classification in 2016. Sasaki H; Yoshida K Neurol Med Chir (Tokyo); 2017 Dec; 57(12):658-666. PubMed ID: 28845038 [TBL] [Abstract][Full Text] [Related]
2. Multidimensional scaling of diffuse gliomas: application to the 2016 World Health Organization classification system with prognostically relevant molecular subtype discovery. Cimino PJ; Zager M; McFerrin L; Wirsching HG; Bolouri H; Hentschel B; von Deimling A; Jones D; Reifenberger G; Weller M; Holland EC Acta Neuropathol Commun; 2017 May; 5(1):39. PubMed ID: 28532485 [TBL] [Abstract][Full Text] [Related]
3. WHO 2016 Classification of gliomas. Wesseling P; Capper D Neuropathol Appl Neurobiol; 2018 Feb; 44(2):139-150. PubMed ID: 28815663 [TBL] [Abstract][Full Text] [Related]
4. Histologic classification of gliomas. Perry A; Wesseling P Handb Clin Neurol; 2016; 134():71-95. PubMed ID: 26948349 [TBL] [Abstract][Full Text] [Related]
5. A simple algorithmic approach using histology and immunohistochemistry for the current classification of adult diffuse glioma in a resource-limited set-up. Rajeswarie RT; Rao S; Nandeesh BN; Yasha TC; Santosh V J Clin Pathol; 2018 Apr; 71(4):323-329. PubMed ID: 28801347 [TBL] [Abstract][Full Text] [Related]
6. Prognostic impact of the 2016 WHO classification of diffuse gliomas in the French POLA cohort. Tabouret E; Nguyen AT; Dehais C; Carpentier C; Ducray F; Idbaih A; Mokhtari K; Jouvet A; Uro-Coste E; Colin C; Chinot O; Loiseau H; Moyal E; Maurage CA; Polivka M; Lechapt-Zalcman E; Desenclos C; Meyronet D; Delattre JY; Figarella-Branger D; Acta Neuropathol; 2016 Oct; 132(4):625-34. PubMed ID: 27573687 [TBL] [Abstract][Full Text] [Related]
7. DNA methylation signatures for 2016 WHO classification subtypes of diffuse gliomas. Paul Y; Mondal B; Patil V; Somasundaram K Clin Epigenetics; 2017; 9():32. PubMed ID: 28392842 [TBL] [Abstract][Full Text] [Related]
8. The Role of Molecular Diagnostics in the Management of Patients with Gliomas. Wirsching HG; Weller M Curr Treat Options Oncol; 2016 Oct; 17(10):51. PubMed ID: 27501915 [TBL] [Abstract][Full Text] [Related]
9. Characterization of gliomas: from morphology to molecules. Ferris SP; Hofmann JW; Solomon DA; Perry A Virchows Arch; 2017 Aug; 471(2):257-269. PubMed ID: 28674742 [TBL] [Abstract][Full Text] [Related]
10. Anaplastic gliomas in adults: an update. Izquierdo C; Joubert B; Ducray F Curr Opin Oncol; 2017 Nov; 29(6):434-442. PubMed ID: 28901965 [TBL] [Abstract][Full Text] [Related]
11. Molecular classification of anaplastic oligodendroglioma using next-generation sequencing: a report of the prospective randomized EORTC Brain Tumor Group 26951 phase III trial. Dubbink HJ; Atmodimedjo PN; Kros JM; French PJ; Sanson M; Idbaih A; Wesseling P; Enting R; Spliet W; Tijssen C; Dinjens WN; Gorlia T; van den Bent MJ Neuro Oncol; 2016 Mar; 18(3):388-400. PubMed ID: 26354927 [TBL] [Abstract][Full Text] [Related]
12. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene. Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179 [TBL] [Abstract][Full Text] [Related]
13. [Histological and molecular classification of gliomas]. Figarella-Branger D; Colin C; Coulibaly B; Quilichini B; Maues De Paula A; Fernandez C; Bouvier C Rev Neurol (Paris); 2008; 164(6-7):505-15. PubMed ID: 18565348 [TBL] [Abstract][Full Text] [Related]
14. Whole genome analysis from microdissected tissue revealed adult supratentorial grade II-III gliomas are divided into clinically relevant subgroups by genetic profile. Hirose Y; Sasaki H; Miwa T; Ohba S; Ikeda E; Abe M; Ikeda S; Kobayashi M; Kawase T; Hasegawa M; Yoshida K Neurosurgery; 2011 Aug; 69(2):376-90. PubMed ID: 21358357 [TBL] [Abstract][Full Text] [Related]
15. Diffuse low-grade glioma: a review on the new molecular classification, natural history and current management strategies. Delgado-López PD; Corrales-García EM; Martino J; Lastra-Aras E; Dueñas-Polo MT Clin Transl Oncol; 2017 Aug; 19(8):931-944. PubMed ID: 28255650 [TBL] [Abstract][Full Text] [Related]
17. Diffuse Infiltrating Oligodendroglioma and Astrocytoma. van den Bent MJ; Smits M; Kros JM; Chang SM J Clin Oncol; 2017 Jul; 35(21):2394-2401. PubMed ID: 28640702 [TBL] [Abstract][Full Text] [Related]
18. [Classification and grading of gliomas and meningiomas]. Niedermayer I; Kolles H; Feiden W Radiologe; 1998 Nov; 38(11):888-97. PubMed ID: 9861648 [TBL] [Abstract][Full Text] [Related]
19. [WHO classification of tumours of the CNS: revised edition of 2007 with critical comments on the typing und grading of common-type diffuse gliomas]. Feiden S; Feiden W Pathologe; 2008 Nov; 29(6):411-21. PubMed ID: 18820922 [TBL] [Abstract][Full Text] [Related]
20. Molecularly based management of gliomas in clinical practice. Rudà R; Pellerino A; Magistrello M; Franchino F; Pinessi L; Soffietti R Neurol Sci; 2015 Sep; 36(9):1551-7. PubMed ID: 26194534 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]